A surge in unapproved online sales and self-use of Mounjaro (a type 2 diabetes drug repurposed for weight loss) in Japan has led to widespread illegal disposal of used injection needles, posing serious infection risks. For overseas aesthetic buyers and distributors, this highlights critical regulatory and waste-management challenges in the medical aesthetics supply chain, especially for injectables and consumables.
Regulatory crackdown on unauthorized sales
On June 2, Osaka Prefectural Police sent three individuals in their 20s and 30s to prosecutors for allegedly selling and transferring Mounjaro without a license via social media, violating the Pharmaceutical and Medical Device Act. Health Minister Kenichiro Ueno stated on June 5 that private sales of Mounjaro are illegal. This underscores the strict regulatory environment surrounding off-label aesthetic use of prescription drugs in Japan.
Needle disposal crisis and infection hazards
Used Mounjaro needles are classified as medical waste due to the risk of needle-stick injuries and bloodborne infections such as hepatitis B and C. However, many users who purchase the drug online are unaware of proper disposal methods and discard needles with household trash or in public bins. A survey by Mirai Medical Clinic found that nearly 80% of 139 Mounjaro users reported inconvenience in disposing of used needles.
Real incident at Tokyo Metro station
Tokyo Metro confirmed a past accident at Jimbocho Station where a cleaner accidentally pricked their finger on a used needle discarded in a women's restroom. The station now posts warnings asking users to take used needles home. Although that incident did not involve Mounjaro, the rise in online purchases increases the likelihood of such accidents as needles circulate outside regulated channels.
What buyers should watch
For importers and distributors of aesthetic injectables, this case emphasizes the need for clear disposal instructions and take-back programs. Clinics and suppliers should ensure that patients receive proper guidance on returning used needles to clinics or pharmacies. Failure to manage waste can lead to public health risks, legal liability, and reputational damage. Compliance with local medical waste regulations is critical for market access and safety.
Sourcing context
Mounjaro is not approved for aesthetic use in Japan, yet it is prescribed off-label by beauty clinics. This gray market creates supply-chain vulnerabilities, including counterfeit products and improper handling. Overseas buyers should verify that their suppliers adhere to strict regulatory standards and provide end-to-end waste management solutions for injectables.
Source: Read the original report | Published: June 10, 2025